Graham K. Cooper is Treasurer at Orexigen Therapeutics, Inc. (OREX). They have made 4 open-market trades across 2 companies since 2007, most recently 2021-07-06.
CIK 0001396943
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BEAM | SELL | 2021-07-06 | 2021-07-08 | $119.61 | $386K | -5.7% | +6.3% | -16.6% |
| BEAM | SELL | 2021-06-28 | 2021-06-30 | $106.13 | $2.4M | -29.9% | -28.9% | -29.6% |
| RCPT | SELL · 10b5-1 | 2014-09-16 | 2014-09-17 | $61.30 | $3.1M | N/A | N/A | N/A |
| OREX | SELL | 2009-12-21 | 2009-12-23 | $8.22 | $678K | N/A | N/A | N/A |
| OREX | SELL | 2009-12-21 | 2009-12-23 | $8.39 | $147K | N/A | N/A | N/A |
| OREX | SELL · 10b5-1 | 2008-08-21 | 2008-08-25 | $12.00 | $99K | N/A | N/A | N/A |
| OREX | SELL · 10b5-1 | 2007-12-20 | 2007-12-21 | $14.09 | $56K | N/A | N/A | N/A |
| OREX | SELL · 10b5-1 | 2007-11-20 | 2007-11-21 | $14.74 | $59K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.